Trial reportJournal of periodontology2026
Electrolyzed saline as an alternative to chlorhexidine: Antimicrobial and biofilm volume outcomes in a 4-day non-brushing randomized controlled clinical trial.
Trial report in Journal of periodontology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05709015 (Evaluation of a Mouthwash Formulation Containing Neutral Electrolysed Water on De-novo Plaque Formation, Gingival Inflammation, MMP-8 Activity and the Oral Microbiome), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Evaluation of a Mouthwash Formulation Containing Neutral Electrolysed Water on De-novo Plaque Formation, Gingival Inflammation, MMP-8 Activity and the Oral Microbiome
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundThe biofilm-inhibitory effects of electrolyzed saline (EOS) vary widely due to differences in formulations and treatment methods. This study analyzed the impact of EOS on key oral microbial species and used serial 3D-intraoral scans to evaluate its effects on de novo biofilm formation.
methodsThis was a double-blind, randomized, placebo-controlled, cross-over, 4-day, non-brushing, plaque-regrowth study on periodontally healthy individuals. Each subject participated in three trial arms. During each 4-day arm, the subjects refrained from mechanical oral hygiene. Instead, they rinsed their oral cavities twice-daily with EOS, 0.12% chlorhexidine (CHX), or placebo. De novo plaque accumulation after 4 days was assessed as the primary outcome using the Turesky Modification of the Quigley-Hein Plaque Index (TMQHPI) and the volumetric plaque index (VPI). qPCR analyses of key-microbial species and measurements of active-matrix-metalloproteinase-8 (aMMP-8) in gingival crevicular fluid were performed to complement the clinical data.
resultsThe biofilm-inhibitory effect of CHX was superior to that of EOS at the level of TMQHPlI and VPI, although both significantly reduced biofilms compared with placebo. The broad-spectrum antimicrobial effect of CHX caused significant reductions in overall bacterial loads, while the action of EOS was more selective. Both CHX and EOS markedly reduced the bacterial loads of Tannerella forsythia; CHX remained more effective against Treponema denticola. In contrast, only EOS demonstrated stronger antimicrobial effects against Fusobacterium nucleatum and Prevotella intermedia while showing no significant impact on periodontal commensals. No significant effects on aMMP-8 were observed.
conclusionsEOS showed substantial, but inferior biofilm-inhibitory, effects compared with CHX. However, EOS had more selective and dysbiosis-controlling effects than CHX. The clinical trial was registered at Clintrials.gov under no. NCT05709015. PLAIN LANGUAGE SUMMARY: This study investigated the effectiveness of electrolyzed saline (EOS) in preventing biofilm build-up on teeth. The efficacy of EOS mouthwash was compared with a positive control (chlorhexidine, CHX) and a negative control (distilled water). A method based on 3D scans of teeth was used to measure changes in the biofilm volume. In the study, participants stopped brushing their teeth for 4 days and rinsed their mouths twice daily with either EOS, CHX, or a placebo instead. They were then assessed for biofilm levels and changes in oral bacteria numbers. The results showed that CHX was more effective than EOS in reducing biofilm, although both were more effective than placebo. Chlorhexidine significantly lowered harmful bacteria but also negatively affected the beneficial bacteria. On the other hand, EOS also reduced specific harmful bacteria, but did not lower the beneficial ones as much. Overall, while EOS was less effective at reducing biofilm than CHX, it was better at maintaining a healthy balance of oral bacteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.